Kyras Therapeutics Inc. operates as a biotechnology company that develops drugs for incurable cancers and developmental disorders.

Kyras Therapeutics, Inc.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.kyrasrx.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address430 East 29th Street Suite 1005,NY,10016New YorkUnited States
430 East 29th Street Suite 1005,NY,10016
New York
United States
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]